HQL logo

Tekla Life Sciences Investors (HQL) EBIT

Quarterly EBIT

N/A

30 September 2024

HQL Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBIT

N/A

30 September 2024

HQL TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HQL EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

HQL EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time

Tekla Life Sciences Investors EBIT History

DateAnnualQuarterlyTTM
Mar 2020
-
$60.85 M(-199.0%)
-$586.09 K(-99.0%)
Sept 2019
-
-$61.43 M(<-9900.0%)
-$61.43 M(-162.3%)
DateAnnualQuarterlyTTM
Mar 2019
-
$0.00(-100.0%)
$98.64 M(0.0%)
Sept 2018
-
$98.64 M
$98.64 M

FAQ

  • What is the all time high quarterly EBIT for Tekla Life Sciences Investors?
  • What is the all time high TTM EBIT for Tekla Life Sciences Investors?

What is the all time high quarterly EBIT for Tekla Life Sciences Investors?

Tekla Life Sciences Investors all-time high quarterly earnings before interest & taxes is $98.64 M

What is the all time high TTM EBIT for Tekla Life Sciences Investors?

Tekla Life Sciences Investors all-time high TTM earnings before interest & taxes is $98.64 M